Works by Kurata, Takayasu

Results: 68
    1
    2

    Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, which was administered to patients with advanced solid tumors on days 1 and 8 in 3-week courses.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 2, p. 285, doi. 10.1007/s00280-006-0382-7
    By:
    • Tamura, Kenji;
    • Nakagawa, Kazuhiko;
    • Kurata, Takayasu;
    • Satoh, Taroh;
    • Nogami, Toshiji;
    • Takeda, Koji;
    • Mitsuoka, Shigeki;
    • Yoshimura, Naruo;
    • Kudoh, Shinzoh;
    • Negoro, Shunichi;
    • Fukuoka, Masahiro
    Publication type:
    Article
    3
    4

    Investigation of a practical assessment index to capture the clinical presentation of cachexia in patients with lung cancer.

    Published in:
    Japanese Journal of Clinical Oncology, 2024, v. 54, n. 3, p. 305, doi. 10.1093/jjco/hyad177
    By:
    • Katsushima, Utae;
    • Hase, Kimitaka;
    • Fukushima, Takuya;
    • Kubo, Takanari;
    • Nakano, Jiro;
    • Ogushi, Naoya;
    • Okuno, Yukiko;
    • Kamisako, Keisuke;
    • Nakanishi, Kentaro;
    • Okazaki, Yuta;
    • Ikoma, Tatsuki;
    • Takeyasu, Yuki;
    • Yamanaka, Yuta;
    • Yoshioka, Hiroshige;
    • Imai, Yoshie;
    • Kurata, Takayasu
    Publication type:
    Article
    5
    6

    Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subset.

    Published in:
    Japanese Journal of Clinical Oncology, 2018, v. 48, n. 4, p. 367, doi. 10.1093/jjco/hyy016
    By:
    • Katsuyuki Kiura;
    • Fumio Imamura;
    • Hiroshi Kagamu;
    • Shingo Matsumoto;
    • Toyoaki Hida;
    • Kazuhiko Nakagawa;
    • Miyako Satouchi;
    • Isamu Okamoto;
    • Mitsuhiro Takenoyama;
    • Yasuhito Fujisaka;
    • Takayasu Kurata;
    • Masayuki Ito;
    • Kota Tokushige;
    • Hatano, Ben;
    • Makoto Nishio
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13

    First-Line Chemoimmunotherapy versus Sequential Platinum-Based Chemotherapy Followed by Immunotherapy in Patients with Non-Small Cell Lung Cancer with ≤49% Programmed Death-Ligand 1 Expression: A Real-World Multicenter Retrospective Study.

    Published in:
    Cancers, 2023, v. 15, n. 20, p. 4988, doi. 10.3390/cancers15204988
    By:
    • Tanimura, Keiko;
    • Takeda, Takayuki;
    • Kataoka, Nobutaka;
    • Yoshimura, Akihiro;
    • Nakanishi, Kentaro;
    • Yamanaka, Yuta;
    • Yoshioka, Hiroshige;
    • Honda, Ryoichi;
    • Uryu, Kiyoaki;
    • Fukui, Mototaka;
    • Chihara, Yusuke;
    • Takei, Shota;
    • Kawachi, Hayato;
    • Yamada, Tadaaki;
    • Tamiya, Nobuyo;
    • Okura, Naoko;
    • Yamada, Takahiro;
    • Murai, Junji;
    • Shiotsu, Shinsuke;
    • Kurata, Takayasu
    Publication type:
    Article
    14

    Age-Stratified Analysis of First-Line Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer: Real-World Evidence from a Multicenter Retrospective Study.

    Published in:
    Cancers, 2023, v. 15, n. 5, p. 1543, doi. 10.3390/cancers15051543
    By:
    • Takeda, Takayuki;
    • Yamada, Tadaaki;
    • Kunimatsu, Yusuke;
    • Tanimura, Keiko;
    • Morimoto, Kenji;
    • Shiotsu, Shinsuke;
    • Chihara, Yusuke;
    • Okada, Asuka;
    • Horiuchi, Shigeto;
    • Hibino, Makoto;
    • Uryu, Kiyoaki;
    • Honda, Ryoichi;
    • Yamanaka, Yuta;
    • Yoshioka, Hiroshige;
    • Kurata, Takayasu;
    • Takayama, Koichi
    Publication type:
    Article
    15
    16
    17

    A phase I study of S-1 with concurrent radiotherapy in elderly patients with locally advanced non-small cell lung cancer.

    Published in:
    Investigational New Drugs, 2013, v. 31, n. 3, p. 599, doi. 10.1007/s10637-012-9833-7
    By:
    • Hasegawa, Yoshikazu;
    • Okamoto, Isamu;
    • Takezawa, Ken;
    • Miyazaki, Masaaki;
    • Tsurutani, Junji;
    • Yonesaka, Kimio;
    • Morinaga, Ryotaroh;
    • Tsuya, Asuka;
    • Terashima, Masaaki;
    • Kudoh, Toshihiro;
    • Azuma, Koichi;
    • Kurata, Takayasu;
    • Nishikawa, Tatsuyuki;
    • Fukuoka, Masahiro;
    • Nishimura, Yasumasa;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    18
    19
    20
    21

    Evaluation of FOLFOX or CAPOX reintroduction with or without bevacizumab in relapsed colorectal cancer patients treated with oxaliplatin as adjuvant chemotherapy (REACT study).

    Published in:
    International Journal of Clinical Oncology, 2020, v. 25, n. 8, p. 1515, doi. 10.1007/s10147-020-01701-1
    By:
    • Kotaka, Masahito;
    • Iwamoto, Shigeyoshi;
    • Satake, Hironaga;
    • Sakai, Daisuke;
    • Kudo, Toshihiro;
    • Fukunaga, Mutsumi;
    • Konishi, Ken;
    • Ide, Yoshihito;
    • Ikumoto, Taro;
    • Tsuji, Akihito;
    • Sano, Yasushi;
    • Kato, Takeshi;
    • Sugimoto, Naotoshi;
    • Satoh, Taroh;
    • Kanazawa, Akiyoshi;
    • Kurata, Takayasu;
    • Yamanaka, Takeharu;
    • Tomita, Naohiro
    Publication type:
    Article
    22
    23
    24

    Comparative Study on Associations Between Lung Cancer Prognosis and Diagnostic Criteria Set by the European Palliative Care Research Collaboration and the Asian Working Group for Cachexia.

    Published in:
    Thoracic Cancer, 2025, v. 16, n. 2, p. 1, doi. 10.1111/1759-7714.15503
    By:
    • Katsushima, Utae;
    • Fukushima, Takuya;
    • Nakano, Jiro;
    • Ogushi, Naoya;
    • Fujii, Kazuki;
    • Nagata, Yutaro;
    • Kamisako, Keisuke;
    • Okuno, Yukiko;
    • Okazaki, Yuta;
    • Nakanishi, Kentaro;
    • Yoshida, Kiyori;
    • Ikoma, Tatsuki;
    • Takeyasu, Yuki;
    • Yamanaka, Yuta;
    • Yoshioka, Hiroshige;
    • Hase, Kimitaka;
    • Kurata, Takayasu
    Publication type:
    Article
    25

    Comparative Study on Associations Between Lung Cancer Prognosis and Diagnostic Criteria Set by the European Palliative Care Research Collaboration and the Asian Working Group for Cachexia.

    Published in:
    Thoracic Cancer, 2025, v. 16, n. 1, p. 1, doi. 10.1111/1759-7714.15503
    By:
    • Katsushima, Utae;
    • Fukushima, Takuya;
    • Nakano, Jiro;
    • Ogushi, Naoya;
    • Fujii, Kazuki;
    • Nagata, Yutaro;
    • Kamisako, Keisuke;
    • Okuno, Yukiko;
    • Okazaki, Yuta;
    • Nakanishi, Kentaro;
    • Yoshida, Kiyori;
    • Ikoma, Tatsuki;
    • Takeyasu, Yuki;
    • Yamanaka, Yuta;
    • Yoshioka, Hiroshige;
    • Hase, Kimitaka;
    • Kurata, Takayasu
    Publication type:
    Article
    26
    27

    Rationale and Design for a Multicenter, Phase II Study of Durvalumab Plus Concurrent Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer: The DOLPHIN Study (WJOG11619L).

    Published in:
    Cancer Management & Research, 2021, v. 13, p. 9167, doi. 10.2147/CMAR.S336262
    By:
    • Tachihara, Motoko;
    • Tsujino, Kayoko;
    • Ishihara, Takeaki;
    • Hayashi, Hidetoshi;
    • Sato, Yuki;
    • Kurata, Takayasu;
    • Sugawara, Shunichi;
    • Okamoto, Isamu;
    • Teraoka, Shunsuke;
    • Azuma, Koichi;
    • Daga, Haruko;
    • Yamaguchi, Masafumi;
    • Kodaira, Takeshi;
    • Satouchi, Miyako;
    • Shimokawa, Mototsugu;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    28
    29

    A Randomized Phase III Study Comparing Carboplatin With Nab-Paclitaxel Versus Docetaxel for Elderly Patients With Squamous-Cell Lung Cancer: Study Protocol.

    Published in:
    2018
    By:
    • Yoshihito Kogure;
    • Hideo Saka;
    • Yuichi Takiguchi;
    • Shinji Atagi;
    • Takayasu Kurata;
    • Noriyuki Ebi;
    • Akira Inoue;
    • Kaoru Kubota;
    • Mitsuhiro Takenoyama;
    • Takashi Seto;
    • Akiko Kada;
    • Takeharu Yamanaka;
    • Masahiko Ando;
    • Nobuyuki Yamamoto;
    • Akihiko Gemma;
    • Yukito Ichinose;
    • Kogure, Yoshihito;
    • Saka, Hideo;
    • Takiguchi, Yuichi;
    • Atagi, Shinji
    Publication type:
    journal article
    30
    31
    32
    33
    34
    35

    Pembrolizumab plus chemotherapy versus chemotherapy alone in patients with advanced non–small cell lung cancer without tumor PD‐L1 expression: A pooled analysis of 3 randomized controlled trials.

    Published in:
    Cancer (0008543X), 2020, v. 126, n. 22, p. 4867, doi. 10.1002/cncr.33142
    By:
    • Borghaei, Hossein;
    • Langer, Corey J.;
    • Paz‐Ares, Luis;
    • Rodríguez‐Abreu, Delvys;
    • Halmos, Balazs;
    • Garassino, Marina C.;
    • Houghton, Baerin;
    • Kurata, Takayasu;
    • Cheng, Ying;
    • Lin, Jianxin;
    • Pietanza, M. Catherine;
    • Piperdi, Bilal;
    • Gadgeel, Shirish M.
    Publication type:
    Article
    36

    Phase 2 study of S-1 and carboplatin plus bevacizumab followed by maintenance S-1 and bevacizumab for chemotherapy-naive patients with advanced nonsquamous non-small cell lung cancer.

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 12, p. 2275, doi. 10.1002/cncr.28048
    By:
    • Urata, Yoshiko;
    • Okamoto, Isamu;
    • Takeda, Masayuki;
    • Hattori, Yoshihiro;
    • Okuno, Keiko;
    • Shimada, Temiko;
    • Kurata, Takayasu;
    • Kaneda, Hiroyasu;
    • Miyazaki, Masaki;
    • Terashima, Masaaki;
    • Tanaka, Kaoru;
    • Morita, Satoshi;
    • Nakagawa, Kazuhiko;
    • Negoro, Shunichi;
    • Satouchi, Miyako
    Publication type:
    Article
    37
    38

    Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non‐small‐cell lung cancer in KEYNOTE‐407.

    Published in:
    Cancer Science, 2023, v. 114, n. 8, p. 3330, doi. 10.1111/cas.15816
    By:
    • Sugawara, Shunichi;
    • Tanaka, Kentaro;
    • Imamura, Fumio;
    • Yamamoto, Nobuyuki;
    • Nishio, Makoto;
    • Okishio, Kyoichi;
    • Hirashima, Tomonori;
    • Tanaka, Hiroshi;
    • Fukuhara, Tatsuro;
    • Nakahara, Yasuharu;
    • Kurata, Takayasu;
    • Katakami, Nobuyuki;
    • Okada, Morihito;
    • Horinouchi, Hidehito;
    • Udagawa, Hibiki;
    • Kasahara, Kazuo;
    • Satouchi, Miyako;
    • Saka, Hideo;
    • Tokito, Takaaki;
    • Hosomi, Yukio
    Publication type:
    Article
    39

    First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset*.

    Published in:
    Cancer Science, 2021, v. 112, n. 12, p. 5000, doi. 10.1111/cas.15144
    By:
    • Satouchi, Miyako;
    • Nosaki, Kaname;
    • Takahashi, Toshiaki;
    • Nakagawa, Kazuhiko;
    • Aoe, Keisuke;
    • Kurata, Takayasu;
    • Sekine, Akimasa;
    • Horiike, Atsushi;
    • Fukuhara, Tatsuro;
    • Sugawara, Shunichi;
    • Umemura, Shigeki;
    • Saka, Hideo;
    • Okamoto, Isamu;
    • Yamamoto, Nobuyuki;
    • Sakai, Hiroshi;
    • Kishi, Kazuma;
    • Katakami, Nobuyuki;
    • Horinouchi, Hidehito;
    • Hida, Toyoaki;
    • Okamoto, Hiroaki
    Publication type:
    Article
    40
    41

    First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset.

    Published in:
    Cancer Science, 2020, v. 111, n. 12, p. 4480, doi. 10.1111/cas.14647
    By:
    • Satouchi, Miyako;
    • Nosaki, Kaname;
    • Takahashi, Toshiaki;
    • Nakagawa, Kazuhiko;
    • Aoe, Keisuke;
    • Kurata, Takayasu;
    • Sekine, Akimasa;
    • Horiike, Atsushi;
    • Fukuhara, Tatsuro;
    • Sugawara, Shunichi;
    • Umemura, Shigeki;
    • Saka, Hideo;
    • Okamoto, Isamu;
    • Yamamoto, Nobuyuki;
    • Sakai, Hiroshi;
    • Kishi, Kazuma;
    • Katakami, Nobuyuki;
    • Horinouchi, Hidehito;
    • Hida, Toyoaki;
    • Okamoto, Hiroaki
    Publication type:
    Article
    42

    Exploration of resistance mechanisms for epidermal growth factor receptor‐tyrosine kinase inhibitors based on plasma analysis by digital polymerase chain reaction and next‐generation sequencing.

    Published in:
    Cancer Science, 2018, v. 109, n. 12, p. 3921, doi. 10.1111/cas.13820
    By:
    • Iwama, Eiji;
    • Sakai, Kazuko;
    • Azuma, Koichi;
    • Harada, Daijiro;
    • Nosaki, Kaname;
    • Hotta, Katsuyuki;
    • Nishio, Makoto;
    • Kurata, Takayasu;
    • Fukuhara, Tatsuro;
    • Akamatsu, Hiroaki;
    • Goto, Koichi;
    • Shimose, Takayuki;
    • Kishimoto, Junji;
    • Nakanishi, Yoichi;
    • Nishio, Kazuto;
    • Okamoto, Isamu
    Publication type:
    Article
    43
    44
    45

    Combined small cell lung carcinoma and giant cell carcinoma: a case report.

    Published in:
    Surgical Case Reports, 2017, v. 3, n. 1, p. 1, doi. 10.1186/s40792-017-0328-9
    By:
    • Saito, Tomohito;
    • Tsuta, Koji;
    • Fukumoto, Kento;
    • Matsui, Hiroshi;
    • Konobu, Toshifumi;
    • Torii, Yoshitaro;
    • Yokoi, Takashi;
    • Kurata, Takayasu;
    • Kurokawa, Hiroaki;
    • Uemura, Yoshiko;
    • Saito, Yukihito;
    • Murakawa, Tomohiro
    Publication type:
    Article
    46
    47
    48

    Impact of the response to platinum-based chemotherapy on the second-line immune checkpoint inhibitor monotherapy in non-small cell lung cancer with PD-L1 expression ≤49%: a multicenter retrospective study.

    Published in:
    Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1303543
    By:
    • Akihiro Yoshimura;
    • Takayuki Takeda;
    • Nobutaka Kataoka;
    • Keiko Tanimura;
    • Mototaka Fukui;
    • Yusuke Chihara;
    • Shota Takei;
    • Hayato Kawachi;
    • Kentaro Nakanishi;
    • Yuta Yamanaka;
    • Nobuyo Tamiya;
    • Ryoichi Honda;
    • Naoko Okura;
    • Takahiro Yamada;
    • Kiyoaki Uryu;
    • Junji Murai;
    • Shinsuke Shiotsu;
    • Hiroshige Yoshioka;
    • Tadaaki Yamada;
    • Takayasu Kurata
    Publication type:
    Article
    49

    Multicenter Pharmacokinetic and Pharmacodynamic Study of Pembrolizumab for Non‐small‐Cell Lung Cancer in Patients Aged 75 Years and Older.

    Published in:
    Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 1042, doi. 10.1002/cpt.3339
    By:
    • Yagishita, Shigehiro;
    • Yamanaka, Yuta;
    • Kurata, Takayasu;
    • Watanabe, Kageaki;
    • Hosomi, Yukio;
    • Horinouchi, Hidehito;
    • Ohe, Yuichiro;
    • Nakahara, Yoshiro;
    • Naoki, Katsuhiko;
    • Asao, Tetsuhiko;
    • Takahashi, Kazuhisa;
    • Saeki, Sho;
    • Sakagami, Takuro;
    • Nakashima, Kazuhisa;
    • Tsubata, Yukari;
    • Fujita, Yu;
    • Wakui, Hiroshi;
    • Furuta, Megumi;
    • Konishi, Jun Sakakibara;
    • Ohuchi, Mayu
    Publication type:
    Article
    50